Stifel analyst cut the price target for Tesla stock.
1 report, 1 independent
Updated Aug 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Stifel analyst cut the price target for Tesla stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Stifel reiterated a Buy rating and target price for Spyre Therapeutics, while Deutsche Bank lowered targets following company results.
- Stifel lowered price target on Viking Holdings Ltd, citing European low-water risk. AQR Capital Management led by Cliff Asness tracks the company.
- Spyre Therapeutics, Inc. was listed on Nasdaq and received analyst ratings from firms including Deutsche Bank and Stifel.